Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty
Open Access
- 23 July 2010
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 9 (1) , 217
- https://doi.org/10.1186/1475-2875-9-217
Abstract
The evolution of drug resistance in malaria parasites highlights a need to identify and evaluate strategies that could extend the useful therapeutic life of anti-malarial drugs. Such strategies are deployed to best effect before resistance has emerged, under conditions of great uncertainty.This publication has 29 references indexed in Scilit:
- Estimating the Global Clinical Burden of Plasmodium falciparum Malaria in 2007PLoS Medicine, 2010
- The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparumTrends in Parasitology, 2009
- A World Malaria Map: Plasmodium falciparum Endemicity in 2007PLoS Medicine, 2009
- The role of anti-malarial drugs in eliminating malariaMalaria Journal, 2008
- Benefits of using multiple first-line therapies against malariaProceedings of the National Academy of Sciences, 2008
- Qinghaosu (Artemisinin): The Price of SuccessScience, 2008
- Revisiting the Basic Reproductive Number for Malaria and Its Implications for Malaria ControlPLoS Biology, 2007
- The Role of Compensatory Mutations in the Emergence of Drug ResistancePLoS Computational Biology, 2006
- Defining the Global Spatial Limits of Malaria Transmission in 2005Advances in Parasitology, 2006
- Do We Need to Put Society First? The Potential for Tragedy in Antimicrobial ResistancePLoS Medicine, 2006